A multi-center, international, randomized, 2-year, parallel-group study to assess the superiority of IVUS-guided PCI versus qualitative angio-guided PCI in unprotected left main coronary artery (ULMCA) disease: Study protocol for OPTIMAL trial.

Autor: Giovanni Luigi De Maria, Luca Testa, Jose M de la Torre Hernandez, Dimitrios Terentes-Printzios, Maria Emfietzoglou, Roberto Scarsini, Francesco Bedogni, Ernest Spitzer, Adrian Banning

Publikováno v: PLoS ONE, Vol 17, Iss 1, p e0260770 (2022)

BackgroundPercutaneous coronary intervention (PCI) is used increasingly for revascularization of unprotected left main coronary artery (LMCA) disease. Observational studies and subgroup analyses from clinical trials, have suggested a possible benefit

Externí odkaz: https://doaj.org/article/1f88d1742cf447398f1acc0b37473985

Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks

Autor: Antonio Landi, Mattia Branca, Pascal Vranckx, Sergio Leonardi, Enrico Frigoli, Dik Heg, Paolo Calabro, Giovanni Esposito, Gennaro Sardella, Carlo Tumscitz, Stefano Garducci, Giuseppe Andò, Ugo Limbruno, Paolo Sganzerla, Andrea Santarelli, Carlo Briguori, Jose M. de la Torre Hernandez, Giovanni Pedrazzini, Stephan Windecker, Marco Valgimigli

Publikováno v: Canadian Journal of Cardiology. 38:1488-1500

The comparative effectiveness of transradial (TRA) compared with transfemoral (TFA) access in acute coronary syndrome (ACS) patients undergoing complex percutaneous coronary intervention (PCI) remains unclear.Among 8404 ACS patients in the Minimising

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1eb3d0846a325624c3a8062ec070ea3
https://doi.org/10.1016/j.cjca.2022.06.014

Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR: Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study

Autor: Anat Berkovitch, Amit Segev, Elad Maor, Alexander Sedaghat, Ariel Finkelstein, Matteo Saccocci, Ran Kornowski, Azeem Latib, Jose M. De La Torre Hernandez, Lars Søndergaard, Darren Mylotte, Niels Van Royen, Azfar G. Zaman, Pierre Robert, Jan-Malte Sinning, Arie Steinvil, Francesco Maisano, Katia Orvin, Gianmarco Iannopollo, Dae-Hyun Lee, Ole De Backer, Federico Mercanti, Kees van der Wulp, Joy Shome, Didier Tchétché, Israel M. Barbash

Publikováno v: Journal of Personalized Medicine; Volume 12; Issue 7; Pages: 1056
Journal of Personalized Medicine, 12
Journal of Personalized Medicine, 12, 7
J Pers Med . 2022 Jun 28;12(7):1056
Berkovitch, A, Segev, A, Maor, E, Sedaghat, A, Finkelstein, A, Saccocci, M, Kornowski, R, Latib, A, Hernandez, J M D L T, Søndergaard, L, Mylotte, D, Royen, N V, Zaman, A G, Robert, P, Sinning, J M, Steinvil, A, Maisano, F, Orvin, K, Iannopollo, G, Lee, D H, Backer, O D, Mercanti, F, van der Wulp, K, Shome, J, Tchétché, D & Barbash, I M 2022, ' Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR : Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study ', Journal of Personalized Medicine, vol. 12, no. 7, 1056 . https://doi.org/10.3390/jpm12071056

Contains fulltext : 283507.pdf (Publisher’s version ) (Open Access) Background: Data to support the routine use of embolic protection devices for stroke prevention during transcatheter aortic valve replacement (TAVR) are controversial. Identifying

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f350c4d9853f9ec009c0c04ad1c852ef

Pre-Hospital Notification in Patients With STEMI: Early Bird Catches the Worm, or at Least Has More Chances

Autor: Jose M. de la Torre Hernandez

Publikováno v: Cardiovascular revascularization medicine : including molecular interventions. 41

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6591ab48e005515abba0ed7d08b674c
https://pubmed.ncbi.nlm.nih.gov/35165049

Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

Autor: Ignacio J, Amat-Santos, Juan P, Sánchez-Luna, Emad, Abu-Assi, María, Melendo-Viu, Ignacio, Cruz-Gonzalez, Luis, Nombela-Franco, Antonio J, Muñoz-Garcí, Sergio G, Blas, Jose M, de la Torre Hernandez, Rafael, Romaguera, Ángel, Sánchez-Recalde, José L, Diez-Gil, Diego, Lopez-Otero, Livia, Gheorge, Borja, Ibáñez, Andrés, Iñiguez-Romo, Sergio, Raposeiras-Roubín, Fernando, Alfonso

Publikováno v: European journal of heart failureReferences. 24(3)

Aims Despite aortic stenosis (AS) relief, patients undergoing transcatheter aortic valve implantation (TAVI) are at increased risk of developing heart failure (HF) within first months of intervention. Sodium-glucose co-transporter 2 (SGLT-2) inhibito

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89cececb641e3772c62af9b30f5da583
https://pubmed.ncbi.nlm.nih.gov/35060254